• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BiZyme:一种通过荧光和抗生素抗性介导痘苗病毒重组体筛选的新型融合蛋白。

BiZyme: a novel fusion protein-mediating selection of vaccinia virus recombinants by fluorescence and antibiotic resistance.

作者信息

Hansen Scott G, Cope Torrey A, Hruby Dennis E

机构信息

Oregon State University, Corvallis, OR 97331, USA.

出版信息

Biotechniques. 2002 May;32(5):1178, 1180, 1182-7. doi: 10.2144/02325dd08.

DOI:10.2144/02325dd08
PMID:12019792
Abstract

Recombinant vaccinia virus is a useful and powerful tool for the expression and study of foreign genes. Methods that are currently available for the selection of vaccinia virus recombinants include the restoration of viral plaque-forming phenotype, the replication of viral DNA in the presence of BUdR or mycophenolic acid, and the maturation and propagation of virus under antibiotic selection. Though effective, each of these methods requires several weeks of concerted effort to isolate, purify, and amplify a potential recombinant virus. Here we report the development of a bifunctional enzyme (BiZyme) to simplify and expedite the isolation and purification of vaccinia virus recombinants. This novel selection marker is composed of an in-frame fusion between the genes encoding gfp and the neomycin phosphotransferase enzyme (neo). Remarkably, expression of the chimeric gfp-neo cassette in the presence of G418 confers both viability and fluorescence to transfected or recombinant virus-infected cells, indicating that both activities are retained within the fusion protein. Therfore, BiZyme was incorporated into a recombination plasmid (pGNR) to enable the concomitant insertion of a foreign gene of interest. Here we demonstrate that this selection/amplification process requires a minimum of 11 days to produce the desired vaccinia virus recombinants. Furthermore, recombinants produced in this fashion have been shown to express both biologically active enzymes and antigenically authenticforeign antigens. In addition to its use in the vaccinia virus vector system, the BiZyme bifunctional selection scheme should be applicable to other eukaryotic and prokaryotic expression systems, simply by coupling it to the appropriate host-specific transcription regulatory signals.

摘要

重组痘苗病毒是用于外源基因表达和研究的一种有用且强大的工具。目前可用于选择痘苗病毒重组体的方法包括病毒蚀斑形成表型的恢复、在存在溴脱氧尿苷(BUdR)或霉酚酸的情况下病毒DNA的复制,以及在抗生素选择下病毒的成熟和增殖。尽管这些方法有效,但每种方法都需要数周的协同努力来分离、纯化和扩增潜在的重组病毒。在此我们报告了一种双功能酶(BiZyme)的开发,以简化和加速痘苗病毒重组体的分离与纯化。这种新型选择标记由编码绿色荧光蛋白(gfp)的基因与新霉素磷酸转移酶(neo)的读框内融合组成。值得注意的是,在存在G418的情况下嵌合gfp-neo盒的表达赋予转染或重组病毒感染细胞活力和荧光,表明两种活性都保留在融合蛋白中。因此,BiZyme被整合到一个重组质粒(pGNR)中,以便能够同时插入感兴趣的外源基因。在此我们证明,这个选择/扩增过程最少需要11天来产生所需的痘苗病毒重组体。此外,以这种方式产生的重组体已被证明能表达具有生物活性的酶和抗原性真实的外源抗原。除了用于痘苗病毒载体系统外,BiZyme双功能选择方案只需将其与适当的宿主特异性转录调控信号偶联,就应该适用于其他真核和原核表达系统。

相似文献

1
BiZyme: a novel fusion protein-mediating selection of vaccinia virus recombinants by fluorescence and antibiotic resistance.BiZyme:一种通过荧光和抗生素抗性介导痘苗病毒重组体筛选的新型融合蛋白。
Biotechniques. 2002 May;32(5):1178, 1180, 1182-7. doi: 10.2144/02325dd08.
2
Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.新霉素抗性作为用于痘苗病毒重组体选择和分离的显性选择标记。
Mol Cell Biol. 1985 Aug;5(8):1918-24. doi: 10.1128/mcb.5.8.1918-1924.1985.
3
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.表达外源基因的感染性痘苗病毒重组体的生产和选择通用方法。
J Virol. 1984 Mar;49(3):857-64. doi: 10.1128/JVI.49.3.857-864.1984.
4
A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts.一种新型痘苗病毒表达系统,无需选择标记、质粒和细菌宿主即可构建重组体。
J Gen Virol. 1995 Dec;76 ( Pt 12):2957-62. doi: 10.1099/0022-1317-76-12-2957.
5
Host range selection of vaccinia recombinants containing insertions of foreign genes into non-coding sequences.含有插入非编码序列的外源基因的痘苗重组体的宿主范围选择。
Vaccine. 1993;11(1):43-53. doi: 10.1016/0264-410x(93)90338-x.
6
Isolation of vaccinia MVA recombinants using the viral F13L gene as the selective marker.使用病毒F13L基因作为选择标记分离痘苗MVA重组体。
Biotechniques. 2005 Nov;39(5):665-6, 668, 670 passim. doi: 10.2144/000112012.
7
Dominant host range selection of vaccinia recombinants by rescue of an essential gene.通过拯救必需基因对痘苗重组体进行主要宿主范围选择。
Virology. 1998 Sep 15;249(1):160-6. doi: 10.1006/viro.1998.9307.
8
Green fluorescent protein expressed by a recombinant vaccinia virus permits early detection of infected cells by flow cytometry.重组痘苗病毒表达的绿色荧光蛋白可通过流式细胞术早期检测受感染的细胞。
J Immunol Methods. 1998 Nov 1;220(1-2):115-21. doi: 10.1016/s0022-1759(98)00156-2.
9
Set of vectors for the expression of histidine-tagged proteins in vaccinia virus recombinants.用于在痘苗病毒重组体中表达组氨酸标签蛋白的载体组。
Biotechniques. 2001 Mar;30(3):524-6, 528-9. doi: 10.2144/01303st03.
10
Transient host range selection for genetic engineering of modified vaccinia virus Ankara.用于安卡拉痘苗病毒基因工程改造的瞬时宿主范围选择
Biotechniques. 2000 Jun;28(6):1137-42, 1144-6, 1148. doi: 10.2144/00286st04.

引用本文的文献

1
Intranasal Immunization with a Vaccinia Virus Vaccine Vector Expressing Pre-Fusion Stabilized SARS-CoV-2 Spike Fully Protected Mice against Lethal Challenge with the Heavily Mutated Mouse-Adapted SARS2-N501Y Strain of SARS-CoV-2.用表达预融合稳定的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)穗蛋白的痘苗病毒疫苗载体进行鼻内免疫,可使小鼠完全免受经高度突变的适应小鼠的SARS-CoV-2 SARS2-N501Y毒株的致死性攻击。
Vaccines (Basel). 2022 Jul 23;10(8):1172. doi: 10.3390/vaccines10081172.
2
Intranasal immunization with a vaccinia virus vaccine vector expressing pre-fusion stabilized SARS-CoV-2 spike fully protected mice against lethal challenge with the heavily mutated mouse-adapted SARS2-N501Y strain of SARS-CoV-2.用表达预融合稳定的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的痘苗病毒疫苗载体进行鼻内免疫,可使小鼠完全免受经高度突变的适应小鼠的SARS-CoV-2 SARS2-N501Y毒株的致死性攻击。
bioRxiv. 2021 Dec 8:2021.12.06.471483. doi: 10.1101/2021.12.06.471483.
3
Vaccinia reporter viruses for quantifying viral function at all stages of gene expression.用于在基因表达各个阶段定量病毒功能的痘苗病毒报告病毒。
J Vis Exp. 2014 May 15(87):51522. doi: 10.3791/51522.
4
Development of Vaccinia reporter viruses for rapid, high content analysis of viral function at all stages of gene expression.痘苗报告病毒的研制用于快速、高通量分析病毒在基因表达的各个阶段的功能。
Antiviral Res. 2011 Jul;91(1):72-80. doi: 10.1016/j.antiviral.2011.04.014. Epub 2011 May 5.
5
Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.通过基因互补策略扩大基于安卡拉痘苗病毒的改良疫苗载体的种类。
PLoS One. 2009;4(5):e5445. doi: 10.1371/journal.pone.0005445. Epub 2009 May 6.